ArticleOpen forum infectious diseases2020

Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature.

Sandra Zingg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.